[go: up one dir, main page]

FR3075001B1 - Utilisation des maltodextrines pour ameliorer la cognition et/ou stimuler le developpement du cerveau - Google Patents

Utilisation des maltodextrines pour ameliorer la cognition et/ou stimuler le developpement du cerveau Download PDF

Info

Publication number
FR3075001B1
FR3075001B1 FR1701309A FR1701309A FR3075001B1 FR 3075001 B1 FR3075001 B1 FR 3075001B1 FR 1701309 A FR1701309 A FR 1701309A FR 1701309 A FR1701309 A FR 1701309A FR 3075001 B1 FR3075001 B1 FR 3075001B1
Authority
FR
France
Prior art keywords
maltodextrins
brain development
stimulate brain
improve cognition
improve
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1701309A
Other languages
English (en)
Other versions
FR3075001A1 (fr
Inventor
Bourgot Cindy Le
Frederique Respondek
Caroline Clouard
Walter Gerrits
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tereos Starch and Sweeteners Belgium
Original Assignee
Tereos Starch and Sweeteners Belgium
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tereos Starch and Sweeteners Belgium filed Critical Tereos Starch and Sweeteners Belgium
Priority to FR1701309A priority Critical patent/FR3075001B1/fr
Priority to PCT/IB2018/060083 priority patent/WO2019116329A1/fr
Publication of FR3075001A1 publication Critical patent/FR3075001A1/fr
Application granted granted Critical
Publication of FR3075001B1 publication Critical patent/FR3075001B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/163—Sugars; Polysaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/60—Feeding-stuffs specially adapted for particular animals for weanlings
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Birds (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Pediatric Medicine (AREA)
  • Molecular Biology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)

Abstract

L'invention concerne l'utilisation d'une maltodextrine ou d'une composition en comprenant comme source principale de glucides pour la nutrition de nourrissons lors de l'enfance précoce d'un mammifère afin d'améliorer ou d'augmenter les performances cognitives et/ou de stimuler le développement du cerveau.
FR1701309A 2017-12-14 2017-12-14 Utilisation des maltodextrines pour ameliorer la cognition et/ou stimuler le developpement du cerveau Active FR3075001B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR1701309A FR3075001B1 (fr) 2017-12-14 2017-12-14 Utilisation des maltodextrines pour ameliorer la cognition et/ou stimuler le developpement du cerveau
PCT/IB2018/060083 WO2019116329A1 (fr) 2017-12-14 2018-12-14 Utilisation de maltodextrine pour augmenter ou améliorer la cognition et/ou stimuler le développement du cerveau

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1701309A FR3075001B1 (fr) 2017-12-14 2017-12-14 Utilisation des maltodextrines pour ameliorer la cognition et/ou stimuler le developpement du cerveau
FR1701309 2017-12-14

Publications (2)

Publication Number Publication Date
FR3075001A1 FR3075001A1 (fr) 2019-06-21
FR3075001B1 true FR3075001B1 (fr) 2021-09-10

Family

ID=61801996

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1701309A Active FR3075001B1 (fr) 2017-12-14 2017-12-14 Utilisation des maltodextrines pour ameliorer la cognition et/ou stimuler le developpement du cerveau

Country Status (2)

Country Link
FR (1) FR3075001B1 (fr)
WO (1) WO2019116329A1 (fr)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2327733A1 (fr) * 1975-10-16 1977-05-13 Lyall Neil Produit de remplacement du lait entier sous forme de poudre
PL1848446T3 (pl) * 2005-02-09 2010-03-31 Vifor Int Ag Zastosowanie kompleksowych związków żelaza(III)
FR2884422B1 (fr) * 2005-04-18 2008-04-11 Roquette Freres Composition anti-inflammatoire de l'intestin comprenant des maltodextrines branchees
EP2422629A1 (fr) * 2010-08-23 2012-02-29 Abbott Laboratories Méthode pour améliorer les performances cognitives et/ou la mémoire utilisant les maltodextrines
CN106615178B (zh) * 2017-01-13 2020-08-04 汉臣氏（沈阳）儿童制品有限公司 Dha藻油固体饮料

Also Published As

Publication number Publication date
FR3075001A1 (fr) 2019-06-21
WO2019116329A1 (fr) 2019-06-20
WO2019116329A8 (fr) 2020-01-30

Similar Documents

Publication Publication Date Title
IL271539A (en) CD73 antibody molecules and their use
WO2016179257A3 (fr) Anticorps anti-cd71, anticorps anti-cd71 activables, et leurs méthodes d'utilisation
HK1259075A1 (zh) Bcma抗体和其用以治疗癌症和免疫病症的用途
WO2016014974A3 (fr) Anticorps anti-cd3, anticorps anti-cd3 activables, anticorps anti-cd3 multispécifiques, anticorps anti-cd3 activables multispécifiques et procédés d'utilisation de ces anticorps
HK1250238A1 (zh) 抗angptl8抗体及其用途
WO2014190356A3 (fr) Anticorps anti-b7-h5 et leurs utilisations
WO2017015622A3 (fr) Protéines de liaison à gdf11 et leurs utilisations
MX2016012282A (es) Metodos para diagnosticar y tratar enfermedad inflamatoria de intestino.
FR3015195B1 (fr) Dispositif de traitement de la chevelure comprenant un joint d'etancheite
WO2014179737A3 (fr) Dosages et procédés de traitement se rapportant à une carence en vitamine d
PH12016501868B1 (en) Gender specific synthetic nutritional compositions and nutritional systems comprising them
FR3075001B1 (fr) Utilisation des maltodextrines pour ameliorer la cognition et/ou stimuler le developpement du cerveau
WO2016090163A3 (fr) Anticorps anti-acétaminophène et produits d'addition acétaminophène-protéine
EP3360880A3 (fr) Procédé
Lalithambigai et al. Chebyshev centers and some geometric properties of Banach spaces
PH12016500128A1 (en) Lactoferrin and memory and learning speed in children
WO2017019673A3 (fr) Méthodes permettant de diagnostiquer et de traiter une maladie inflammatoire de l'intestin
MX2018001924A (es) Composiciones nutritivas sinteticas adaptadas para infantes de edades especificas, y sistemas nutritivos que las comprenden.
Suzuki et al. Erratum to: Milk fortified with vitamin D could reduce the prevalence of vitamin D deficiency among Japanese female college students
WO2014201449A3 (fr) Composants immunosuppresseurs associés à des vecteurs rétroviraux réplicatifs
성신형 A Study of Reconciliation and Peace-Focused on the Barmen Theological Declaration and" 88 Declaration.-
WO2016057726A3 (fr) Anticorps humains anti-vegfr-2/kdr
Kimoto Ginger-induced Ileal Motility is Modified by Stress: Sex Differences in Rats
CN302394547S (zh) 免疫分析仪
Gurkina et al. Prospects of ethnic tourism in the Volga Federal District

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20190621

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9